Blinatumomab Plus Chemo Effective in Aggressive Infant ALL
(MedPage Today) -- Adding a postinduction course of blinatumomab (Blincyto) to chemotherapy appeared safe and highly effective for treating an aggressive form of acute lymphoblastic leukemia (ALL) in infants, according to results from a phase II...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Chemotherapy | Hematology | Leukemia